Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

MRI criteria distinguishing seropositive NMO spectrum disorder from MS.
Mechanisms of action of ACTH in the management of relapsing forms of multiple sclerosis.
Open Label Extension of Prior TERMS Study to Treat Relapsing Forms of Multiple Sclerosis (OLTERMS)
Evidence for a two-stage disability progression in multiple sclerosis.
MS Patients Report Excellent Compliance with Oral Prednisone for Acute Relapses.
Retinal Damage in Multiple Sclerosis Disease Subtypes Measured by High-Resolution Optical Coherence Tomography.
Randomized trial of vaccination in fingolimod-treated patients with multiple sclerosis.
The phosphorylated prodrug FTY720 is a histone deacetylase inhibitor that reactivates ERα expression and enhances hormonal therapy for breast cancer.
Can the ABILHAND handle manual ability in MS?
Co-occurrence of two cases of progressive multifocal leukoencephalopathy in a natalizumab "infusion group"
[Biomarkers in multiple sclerosis].
Regional but Not Global Brain Damage Contributes to Fatigue in Multiple Sclerosis.
Relapsing-Remitting Central Nervous System Autoimmunity Mediated by GFAP-Specific CD8 T Cells.
A genetic variant of the anti-apoptotic protein Akt predicts natalizumab-induced lymphocytosis and post-natalizumab multiple sclerosis reactivation.
Couples coping with multiple sclerosis: a dyadic perspective on the roles of mindfulness and acceptance.
The induction of cell-mediated immunity and tolerance with protein antigens coupled to syngeneic lymphoid cells.
[Processing speed in relapsing-remitting multiple sclerosis: the role played by the depressive symptoms].
Fingolimod in active multiple sclerosis: an impressive decrease in Gd-enhancing lesions.
An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis.
B-cell-directed therapy: which B cells should be targeted and how?
Y-39983, a Selective Rho-Kinase Inhibitor, Attenuates Experimental Autoimmune Encephalomyelitis via Inhibition of Demyelination.
[Current immunotherapy of multiple sclerosis].
Cognitive assessment in MS.
Severely exacerbated neuromyelitis optica rat model with extensive astrocytopathy by high affinity anti-aquaporin-4 monoclonal antibody.
Immunomodulatory Effects of Histone Deacetylase Inhibitors.

Pages